<DOC>
	<DOCNO>NCT01878149</DOCNO>
	<brief_summary>The purpose retrospective clinical evaluation compare VEO® single multilevel result XLIF® single multilevel result relative safety endpoint . This study collect retrospective data subject treat VEO® XLIF® least 3 month prior initiation study . Given fusion generally take least 6 month determine , aim study determine fusion consider short-term ( 6 month ) report adverse event two cohort . Devices use system clear use conform US regulatory requirement . The study employ procedure device use consistent 510 ( k ) , legally clear , label .</brief_summary>
	<brief_title>Retrospective Multicenter Clinical Evaluation Complications Single Multilevel VEO® Lateral Access Interbody Fusion System eXtreme Lateral Interbody Fusion ( XLIF® ) Subjects</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Adult 18 year age old ; Male female VEO® subject previously receive single two level LLIF procedure use VEO® XLIF® system adjunct fusion L2S1 treat degenerative disc disease ( DDD ) treat level ; Subject treat less 3 month prior evaluation LLIF procedure use VEO® XLIF® system participate surgeon . Subject receive LLIF procedure use VEO® XLIF® system fusion L2S1 ; Subjects le 3 month followup data .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>